BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 37592287)

  • 1. Sequence dependencies and mutation rates of localized mutational processes in cancer.
    Poulsgaard GA; Sørensen SG; Juul RI; Nielsen MM; Pedersen JS
    Genome Med; 2023 Aug; 15(1):63. PubMed ID: 37592287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types.
    Chen T; Wang Z; Zhou W; Chong Z; Meric-Bernstam F; Mills GB; Chen K
    BMC Genomics; 2016 Jun; 17 Suppl 2(Suppl 2):394. PubMed ID: 27356755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hotspot propensity across mutational processes.
    Arnedo-Pac C; Muiños F; Gonzalez-Perez A; Lopez-Bigas N
    Mol Syst Biol; 2024 Jan; 20(1):6-27. PubMed ID: 38177930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional mutational signature activities in cancer genomes.
    Timmons C; Morris Q; Harrigan CF
    PLoS Comput Biol; 2022 Dec; 18(12):e1010733. PubMed ID: 36469539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The repertoire of mutational signatures in human cancer.
    Alexandrov LB; Kim J; Haradhvala NJ; Huang MN; Tian Ng AW; Wu Y; Boot A; Covington KR; Gordenin DA; Bergstrom EN; Islam SMA; Lopez-Bigas N; Klimczak LJ; McPherson JR; Morganella S; Sabarinathan R; Wheeler DA; Mustonen V; ; Getz G; Rozen SG; Stratton MR;
    Nature; 2020 Feb; 578(7793):94-101. PubMed ID: 32025018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and genetic determinants of mutation rate variability in regulatory elements of cancer genomes.
    Lee CA; Abd-Rabbo D; Reimand J
    Genome Biol; 2021 May; 22(1):133. PubMed ID: 33941236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear topology modulates the mutational landscapes of cancer genomes.
    Smith KS; Liu LL; Ganesan S; Michor F; De S
    Nat Struct Mol Biol; 2017 Nov; 24(11):1000-1006. PubMed ID: 28967881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational signatures and mutable motifs in cancer genomes.
    Rogozin IB; Pavlov YI; Goncearenco A; De S; Lada AG; Poliakov E; Panchenko AR; Cooper DN
    Brief Bioinform; 2018 Nov; 19(6):1085-1101. PubMed ID: 28498882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of mutational signatures of synonymous mutations across 15 cancer types.
    Bin Y; Wang X; Zhao L; Wen P; Xia J
    BMC Med Genet; 2019 Dec; 20(Suppl 2):190. PubMed ID: 31815613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cancer mutational signatures on transcription factor motifs in the human genome.
    Yiu Chan CW; Gu Z; Bieg M; Eils R; Herrmann C
    BMC Med Genomics; 2019 May; 12(1):64. PubMed ID: 31109337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.
    Wong JKL; Aichmüller C; Schulze M; Hlevnjak M; Elgaafary S; Lichter P; Zapatka M
    Nat Commun; 2022 Jan; 13(1):178. PubMed ID: 35013316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topography of mutational signatures in human cancer.
    Otlu B; Díaz-Gay M; Vermes I; Bergstrom EN; Zhivagui M; Barnes M; Alexandrov LB
    Cell Rep; 2023 Aug; 42(8):112930. PubMed ID: 37540596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of coding and non-coding mutational hotspots in cancer genomes.
    Piraino SW; Furney SJ
    BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer association of DNA repair deficiencies with whole-genome mutational patterns.
    Sørensen SG; Shrikhande A; Poulsgaard GA; Christensen MH; Bertl J; Laursen BE; Hoffmann ER; Pedersen JS
    Elife; 2023 Mar; 12():. PubMed ID: 36883553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Mutational Processes Vary in Their Association with Replication Timing and Chromatin Accessibility.
    Yaacov A; Vardi O; Blumenfeld B; Greenberg A; Massey DJ; Koren A; Adar S; Simon I; Rosenberg S
    Cancer Res; 2021 Dec; 81(24):6106-6116. PubMed ID: 34702725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning mutational signatures and their multidimensional genomic properties with TensorSignatures.
    Vöhringer H; Hoeck AV; Cuppen E; Gerstung M
    Nat Commun; 2021 Jun; 12(1):3628. PubMed ID: 34131135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mutational signatures with yet another package for signature analysis.
    Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
    Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis.
    Zhang J; Liu J; McGillivray P; Yi C; Lochovsky L; Lee D; Gerstein M
    BMC Bioinformatics; 2020 Oct; 21(1):474. PubMed ID: 33092526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genomic characterization of mutational signatures across human cancers.
    Liao J; Bai J; Pan T; Zou H; Gao Y; Guo J; Xu Q; Xu J; Li Y; Li X
    Int J Cancer; 2023 Apr; 152(8):1613-1629. PubMed ID: 36533638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.